Skip to content

BIOLASE, INC.

CIK 0000811240

← back to feed
Revenue (TTM)
$43.46M
+1.4% YoY Q3 Oct 2024
Net Income (TTM)
−$15.3M
+27.9% YoY Q3 Oct 2024
EPS Diluted (TTM)
−$10.83
+93.0% YoY Q3 Oct 2024
Gross Margin
37.0%
Q3 Oct 2024
Operating Margin
-27.9%
Q3 Oct 2024
Net Margin
-35.2%
Q3 Oct 2024
Free Cash Flow (TTM)
−$27.02M
Q3 Oct 2024
Cash
$3.44M
Q3 Oct 2024
Total Debt
$16.04M
Q3 Oct 2024
Shares Outstanding
36.6M sh
Q3 Oct 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings